Lv2
170 积分 2023-12-24 加入
4CMenB journey to the 10-year anniversary and beyond
1天前
待确认
A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults
1天前
已完结
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials
1天前
已完结
Meningococcal serogroup B vaccine (4CMenB): Booster dose in previously vaccinated infants and primary vaccination in toddlers and two-year-old children
1天前
已完结
Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months
1天前
已完结
中国B群脑膜炎奈瑟菌分子流行病学特征分析
1天前
已完结
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage
1天前
已完结
NadA, a novel vaccine candidate of Neisseria meningitidis
1天前
已完结
Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination
2天前
已完结
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study
2天前
已完结
皖公网安备34019202002308
